Business / Finance

RSS

Celgene expands share repurchase program

Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.

18 Aug 2011

Neoprobe sells gamma detection device business to Devicor

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it completed the previously announced sale of its neoprobe GDS line of gamma detection device systems to Devicor Medical Products, Inc. for $30 million in upfront consideration, plus up to an additional $20 million in royalties based on Devicor's achievement of certain revenue milestones.

18 Aug 2011

Paladin to acquire Labopharm

Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.

18 Aug 2011

Sepracor Pharmaceuticals changes company name to Sunovion

Sunovion Pharmaceuticals Canada Inc., formerly Sepracor Pharmaceuticals, Inc., announced today that it has formally changed its name.

18 Aug 2011

Centrify closes Series D round of financing

Centrify Corporation, the leading provider of security and compliance solutions that centrally control, secure and audit both on-premise and cloud-based systems and applications, today announced that it has closed its Series D round of financing.

17 Aug 2011

Neovasc completes previously announced non-brokered private placement

Neovasc Inc. today announced that it has completed a previously announced non-brokered private placement of 4,720,500 equity units at the price of $1.00 per unit for aggregate gross proceeds of approximately $4,720,500.

17 Aug 2011

PAREXEL recognized as Company of the Year for the Pharmaceutical Industry

PAREXEL International Corporation, a leading global biopharmaceutical services provider, has been named Company of the Year for the Pharmaceutical Industry in The Eighth Annual International Business Awards, the only global, all-encompassing business awards program honoring great performances in business.

From Parexel 17 Aug 2011

BioMedGPS launches enterprise-wide Business Intelligence Hub for life science industry

BioMedGPS, the leader in healthcare business intelligence and competitive metrics, today launched the first enterprise-wide Business Intelligence Hub for the life science industry.

17 Aug 2011

Registration now open for California Healthcare Institute's 2011 Annual Meeting

CHI-California Healthcare Institute announced today that registration is now open for CHI's 2011 Annual Meeting. CHI's Annual Meeting focuses on the relationship between biomedical innovation and public policy. This year's theme is Shifting Sands: Forces Reshaping the Biomedical Innovation Business Model.

17 Aug 2011

Biotage net sales increase 12% to 205.8 MSEK for January - June 2011

Biotage: Interim report January - June 2011. Group net sales amounted to 98.6 MSEK (103.5) in the second quarter and to 205.8 MSEK (203.4) in the period January - June. At comparable exchange rates net sales increased by 8 percent in the quarter and by 12 percent the first six months.

17 Aug 2011

GE Healthcare announces acquisition of PAA Laboratories

GE Healthcare, a unit of General Electric Company, today announced it has reached an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.

17 Aug 2011

General Dynamics enters definitive agreement to acquire Vangent

General Dynamics has entered a definitive agreement to acquire Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information-technology and business systems to federal agencies, in a cash transaction valued at approximately $960 million.

17 Aug 2011

BD acquires Carmel Pharma

BD, a leading global medical technology company, today announced the completion of its acquisition of Carmel Pharma, AB, a Swedish company that manufactures the PhaSeal® System, the leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.

From BD (Becton, Dickinson and Company) 17 Aug 2011

Assured Pharmacy second quarter net sales increase 5.3% to $4,169,807

Assured Pharmacy, a leading specialty pharmacy group providing prescription medications to sufferers of chronic pain, announced net sales of $4,169,807 for the quarter ended June 30, 2011, an increase of $211,229 or 5.3%, from $3,958,578 for the second quarter of 2010.

16 Aug 2011

DJOFL second quarter net sales increase 14.5% to $277.8 million

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC, for the second quarter of fiscal 2011, ended July 2, 2011.

16 Aug 2011

Patient Safety Technologies second quarter total revenue decreases to $2.6 million

Patient Safety Technologies, Inc. today announced financial results for its second quarter of 2011 ended June 30, 2011.

16 Aug 2011

Concord Medical second quarter total net revenues increase 24.5% to $19.2 million

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced higher revenues, net income, and earnings per ADS for its unaudited consolidated financial results for the second quarter ended June 30, 2011 compared with the second quarter ended June 30, 2010.

16 Aug 2011

Stellacure to open umbilical cord blood stem cell company in Jordan

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that Stellacure, GmbH, its stem cell company headquartered in Hamburg, Germany, has entered into an agreement with a licensee in Jordan to open an umbilical cord blood stem cell company in that Middle East nation.

16 Aug 2011

China Medical first fiscal quarter net revenues increase 27.4% to US$36.7 million

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, announced its unaudited financial results for the first fiscal quarter ended June 30, 2011 today.

16 Aug 2011